Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. The single enantiomer of the racemate NSAID flurbiprofen, researched but discarded as a treatment for Alzheimer's disease.

Etymologies

Sorry, no etymologies found.

Examples

  • Testing of the amyloid hypothesis began a few years ago with two experimental anti-amyloid drugs, homotaurine and tarenflurbil.

    AARP.org :

  • The researchers found that tarenflurbil had no beneficial effect on the primary outcomes of cognition and activities of daily living after 18 months.

    PhysOrg.com - latest science and technology news stories

  • Patients were randomized to tarenflurbil, 800 mg, or placebo, administered twice a day.

    PhysOrg.com - latest science and technology news stories

  • Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, according to a study in the December

    PhysOrg.com - latest science and technology news stories

  • Green, MD, MPH, of Boston University School of Medicine, shows that the drug tarenflurbil-which aims to suppress the accumulation of amyloid protein (plaque) in brain tissue-did not slow cognitive decline or loss of usual daily activities.

    EurekAlert! - Breaking News

  • M.P.H., of the Boston University Schools of Medicine and Public Health, and colleagues conducted a large phase 3, randomized trial of tarenflurbil for patients with mild AD to determine its efficacy, safety and tolerability.

    PhysOrg.com - latest science and technology news stories

  • Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo.

    Newswise: Latest News

  • Regarding adverse events, more participants taking tarenflurbil than those taking placebo experienced dizziness, upper respiratory tract infections and anemia.

    Newswise: Latest News

  • Newswise - Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, according to a study in the December 16 issue of

    Newswise: Latest News

  • JAMA found that although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo.

    Medindia Health News

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.